Case Study

Nasal Influenza Vaccine

Quintiles helped a customer overcome recruitment and regulatory challenges for a nasal influenza vaccine study in Argentina, Brazil and South Africa.

Learn more

Clinical Services

In a country of 47 million, Quintiles South Africa has fast access to a substantial patient pool supported by more than 1,000 experienced, reliable and motivated investigators representing all therapeutic areas. Our investigator sites have high enrollment, patient retention and compliance rates. These recruitment resources enable flexible, fast study start-up and timely follow-up. And lower infrastructure costs and investigator grants mean significant savings with earlier trial completion. 

Quintiles South Africa specialises in recruiting patients with no prior treatment, and our therapeutic expertise covers a range of medical conditions and diseases. 

Therapeutic Expertise and Disease Profiles

  • Cancer
  • Cardiovascular diseases
  • Diabetes
  • HIV/AIDS
  • Hypertension
  • Malaria and other infectious diseases
  • Psychotic disorders
  • Respiratory infections
  • Tuberculosis

Why Quintiles South Africa Works for You

  • Time zone allows almost full coverage of the business day in Europe and half-day overlap with North America and India.
  • Seasonal studies alternating from the northern hemisphere countries
  • Established infrastructure and access to technology
  • Combination of highly skilled technical staff as well cost-effective sourcing of process-based staff
  • Direct line management involvement in study management with regular scheduled update meetings and established escalation process
  • Uncomplicated regulatory approval process in South Africa, such as:
    • RA & EC submitted in parallel
    • No additional import license required
    • No translations required with initial application – English only
    • Translated patient materials only submitted later during the application process

Contact us
Tel: +27 12 671 2352
Clinical Information